162 related articles for article (PubMed ID: 20143116)
1. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.
Ishikawa Y; Yukawa N; Ohmura K; Hosono Y; Imura Y; Kawabata D; Nojima T; Fujii T; Usui T; Mimori T
Clin Rheumatol; 2010 May; 29(5):563-6. PubMed ID: 20143116
[TBL] [Abstract][Full Text] [Related]
2. A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept.
Ishikawa Y; Yukawa N; Kawabata D; Ohmura K; Fujii T; Usui T; Mimori T
Clin Rheumatol; 2011 Mar; 30(3):429-32. PubMed ID: 21221686
[TBL] [Abstract][Full Text] [Related]
3. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
Leu CC; Lan JL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
[TBL] [Abstract][Full Text] [Related]
4. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Lange U; Piegsa M; Müller-Ladner U; Strunk J
Autoimmunity; 2006 May; 39(3):261-4. PubMed ID: 16769661
[TBL] [Abstract][Full Text] [Related]
5. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
Nagashima T; Minota S
Clin Rheumatol; 2010 Jul; 29(7):819-20. PubMed ID: 20405301
[No Abstract] [Full Text] [Related]
6. New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.
Brunasso AM; Aberer W; Massone C
ScientificWorldJournal; 2014; 2014():179180. PubMed ID: 24600322
[TBL] [Abstract][Full Text] [Related]
7. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
Williams VL; Cohen PR
Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
[TBL] [Abstract][Full Text] [Related]
8. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
Kang MJ; Lee YH; Lee J
J Korean Med Sci; 2006 Oct; 21(5):946-9. PubMed ID: 17043436
[TBL] [Abstract][Full Text] [Related]
9. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
10. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.
Löhr HF; Böcher WO; Hermann E; Müller-Quernheim J; Schwickert H; Meyer zum Büschenfelde KH; Gerken G
Z Rheumatol; 1993; 52(5):307-11. PubMed ID: 8259723
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of rheumatoid arthritis developed after polymyositis].
Miyoshi T; Yoshinaga Y; Ota Y
Ryumachi; 2003 Jun; 43(3):583-90. PubMed ID: 12910969
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational study.
Bingham CO; Ince A; Haraoui B; Keystone EC; Chon Y; Baumgartner S
Curr Med Res Opin; 2009 May; 25(5):1131-42. PubMed ID: 19317607
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
[TBL] [Abstract][Full Text] [Related]
15. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody.
Jenkins EA; Hull RG; Thomas AL
Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis.
Vázquez-Abad D; Rothfield NF
Arthritis Rheum; 1996 Feb; 39(2):292-6. PubMed ID: 8849382
[TBL] [Abstract][Full Text] [Related]
17. Etanercept-induced systemic lupus erythematosus.
Swale VJ; Perrett CM; Denton CP; Black CM; Rustin MH
Clin Exp Dermatol; 2003 Nov; 28(6):604-7. PubMed ID: 14616825
[TBL] [Abstract][Full Text] [Related]
18. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review].
Marie I; Lahaxe L; Tiev K; Duval-Modeste AB; Vittecoq O; Levesque H; Jouen F
Rev Med Interne; 2010 Aug; 31(8):540-4. PubMed ID: 20510485
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients.
Cavazzana I; Bobbio-Pallavicini F; Franceschini F; Bazzani C; Ceribelli A; Bravi E; Zingarelli S; Caporali R; Cattaneo R; Montecucco CM
Clin Exp Rheumatol; 2007; 25(5):676-83. PubMed ID: 18078613
[TBL] [Abstract][Full Text] [Related]
20. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
